Mr. Gilliam
Chairman
10x Genomics, Inc. (TXG)Equibles does not estimate personal net worth.
Get an email with a short summary when 10x Genomics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TXG alertsAbout Mr. Gilliam
Mr. Gilliam is recorded as Chairman at 10x Genomics, Inc. (TXG) since October 30, 2026. 10x Genomics, Inc. reported in an 8-K filed November 2, 2026 that Mr. Gilliam was appointed Chair of the Audit Committee of the Board of Directors, effective October 30, 2026. 10x Genomics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at 10x Genomics, Inc. includes Serge Saxonov (CEO and Board Member), John R. Stuelpnagel (Chairman and Board Member), Adam S. Taich (CFO) and 7 others.
“On October 30, 2026, Mr. Gilliam was appointed Chair of the Audit Committee of the Board of Directors, for which he shall receive an annual retainer of $25,000 (prorated as necessary).”
Affiliation history
-
Current
2026-10-30–present
Company network
Leadership on record at 10x Genomics, Inc.
- Serge Saxonov CEO, Board Member
- John R. Stuelpnagel Chairman, Board Member
- Adam S. Taich CFO
- Randy Wu General Counsel
- Alan Mateo Board Member
- Alan V. Mateo Board Member
- Ansuman Satpathy Board Member
- Benjamin J. Hindson Board Member
- Joseph Gilliam Board Member
- Kimberly J. Popovits Board Member